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Abstract
Background: The colon plays a key role in regulating the homeostasis of  bile acids.
Aim: The present study aims to evaluate the influence of  colon cancer towards the homeostasis of  bile acids.
Methods: The free and conjugated bile acids were determined using ultraperformance LC (UPLC) coupled with ABI 4000 
QTRAP triple quadrupole instruments.
Results: The results showed that the free bile acids in serum of  patients with colon cancers  tend to increase,  and the con-
jugated  bile acids tended to decrease, especially for taurolithocholate (TLCA) (p<0.001).
Conclusion:  The  alteration  of   bile  acids  balance  in  colon  cancers  indicated  the possibility of  complicated diseases 
due to the disrupted balance of  bile acids.
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Introduction
Bile acids, the main constituents of  bile, are produced 
in the liver from cholesterol through a series of  enzyme 
modification. Bile acids play a key role in solubilization 
and emulsification  of  fat to help digestion  in the di-
gestive  tract1. Colon plays an important  role  in  the 
modification  of   bile  acids.  For  example,  in  the  ile-
um,  the enzymes released by intestinal flora can modify 
the deconjugated bile acids2. In the ileum and colon, 
bile acids will be re-absorbed into the liver for recycling. 
Therefore, the diseases influencing colon might disturb 
the homeostasis of  bile acids.
Colon cancer, also known as colorectal cancer, has been 
defined as the cancer from uncontrolled cell growth in 
the colon3. Previous studies have demonstrated that 11 
out of  26 serum amino acids significantly changed in 
colon cancer, including lysine, alanine,  aspartic  acid, 
glycine,  histidine,  leucine,  methionine,  sarcosine, 
threonine, tyrosine,   and   valine4,  indicating   the   dis-
ruption   of   amino   acids   metabolism. Additionally, in 
the colon cancer, the lipid metabolic profile significantly 
changed5. The present study aims to compare the bile 
acids profile between normal individuals and patients 
with colon cancer. 
Materials and methods 
Reagents
Hyodeoxycholic acid (HDCA), lithocholic acid (LCA), 
sodium taurochenodeoxycholate (TCDCA), taurochol-
ic acid sodium salt hydrate (TCA), sodium chenode-
oxycholate (CDCA), sodium taurolithocholate (TLCA), 
ursodeoxycholic acid (UDCA), cholic acid (CA), dehy-
drocholic acid (DHCA), sodium deoxycholate (DCA), 
sodium tauroursodeoxycholate (TUDCA), sodium tau-
rodeoxycholate   hydrate  (TDCA),  and  glycocholic 
acid  hydrate  (GCA)  were purchased from Sigma-
Aldrich  (St Louis, MO). The purity of  all these bile ac-
ids standards  was above  95%,  and they were  dissolved 
in the dimethyl  sulfoxide (DMSO) for utilization.
Determination of  bile acids components in healthy vol-
unteers and patients,5 healthy volunteers and 5 patients 
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with colon cancers were enrolled in the Tangdu Hospi-
tal, Fourth Military Medical University. The blood was 
taken, and serum was prepared  through  centrifugation 
for 15  min  at  8000×g  in  BD  microtainer  serum 
separator  tubes.  The  serum  was  determined  using 
UltraPerformance  LC  (UPLC) coupled with ABI 4000 
QTRAP triple quadrupole instruments. 0.3 ml/min 
flow rate was used, and the elution phase contained wa-
ter containing 0.2% formic acid (A) and methanol  (B). 
The following  conditions  were used:  0-3 min, 65-75% 
B; 3-8 min, 75-80% B; 8-12 min, 80-95% B; 12-14 min, 
65% B. MS source parameters were as follows: capillary 
voltage, 2.9 kV; cone voltage, 36 V; source temperature, 
90 °C; and cone gas flow rate, 40 L/h at 4 psi.
Statistical analysis
The results were given as mean ± standard deviation 
(SD). Statistical differences were evaluated using the 
two-tailed Student’s t-test and considered significant at 
the *p < 0.05, **p <0.01, ***p<0.001 level.
Results
Given  the difficulty  to separate  numerous  bile acids, 
multiple  reaction  monitoring (MRM) was performed. 
The ion pair (Q1→Q3, 391.1→391.1) was used to 
separate HDCA, CDCA, DCA and UDCA, and the re-
tention time was 6 min, 8.55 min, 8.93 min, and 5.45 
min, respectively. The ion pair (Q1→Q3, 375.1→375.1) 
was employed to separate LCA. The ion pair (Q1→Q3, 
498.1→79.9) was used to separate TCDCA (Rt=8.95 
min), TUDCA (Rt=5.51 min), and TDCA, respectively 
(Rt=9.68 min). The ion pair (Q1→Q3, 407.2→407.2) 
was employed to identify CA. GCA was separated 
using the ion pair 464.2→73.9 (Q1→Q3). The separa-
tion of  TCA and TLCA used the ion pairs 514.2→79.8 
(Q1→Q3) and 482.2→79.9 (Q1→Q3), respectively.
Using this monitoring method, the serum level of  bile 
acids including free bile acids and conjugated bile acids 
was determined in five healthy volunteers and five pa-
tients with   colon   cancers. The   relatively   big  differ-
ence   was   observed   between   the individuals (Fig. 1 
& Fig. 2). 
Fig. 1 Comparison  of  free bile acids levels between  healthy  volunteers  (n=5) and patients  with  colon 
cancers  (n=5).  The  data  were  given  as  mean  plus  standard deviation (S.D.). N.S., not significant.
Fig. 2 Comparison of  conjugated bile acids levels between healthy volunteers (n=5) and patients with 
colon cancers (n=5). The data was given as mean plus standard deviation (S.D.). N.S., 
not significant, ***, p<0.001.
For free bile acids, compared with healthy volunteers, 
the increase trend was observed for HDCA, CDCA, 
DCA, and UDCA (although not significantly),  respec-
tively.  The  levels  of  the  conjugated  bile  acids  (TCA, 
TLCA, GCA, TCDCA,  TUDCA,  TDCA) decreased 
in patients with colon cancer, and the serum  level  of  
TLCA  in  patients  with  colon  cancer  significantly 
decreased  in comparison with the health volunteers.
Discussion
After synthesis, most of  bile acids immediately undergo 
the conjugation process with amino acids (glycine and 
taurine) to form the corresponding conjugates catalyzed 
by bile acid coenzyme A synthase (BACS) and bile acid 
amino acid transferase (BAAT)6.
Like drug conjugations,  bile acids conjugates  prevent 
Ca2+  precipitation,  minimize passive   absorption, 
and  greatly   prepare   bile  acids   for  efficient   trans-
port   and detoxification6. In the intestine, the conju-
gated bile acids can be deconjugated. Colorectal cancer 
(CRC), the third most common cancer in both men and 
women, has been regarded as the second leading cause 
of  cancer death in the United States7. In the  patients 
with  colon  cancers,  many  normal  functions  might 
be  damaged.  For example,  the iron homeostasis  will 
be disrupted  through the influence  towards the expres-
sion  of  iron uptake and export proteins,  such as diva-
lent metal transporter-1 (DMT-1), ferroportin (FPN), 
and hephaestin (HEPH)8.
In the present study, the conjugation reaction of  bile 
acids was demonstrated  to be strongly affected in colon 
cancer, resulting the increased levels of  free bile acids 
and decreased levels of  bile acids conjugates in serum. 
This alteration of  bile acids homeostasis  can result  in 
the change  of   some  physiological  function  due  to 
their important roles as cell signaling molecules9. For 
example, the activity of  farnesoid X receptor (FXR) can 
be activated by chenodeoxycholic acid (CDCA), deoxy-
cholic acid (DCA), and lithocholic acid (LCA), and the 
activation of  FXR enhances hepatocyte chemoprotec-
tion and liver tumor chemoresistance against genotoxic 
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compounds10,11. Therefore, the increased levels of  free 
bile acids in colon cancers might significantly induce 
the chemoresistance towards the anti-tumor drugs for 
colon cancers. It should be noted that the enzyme-cat-
alyzed synthesis of  bile acids might be affected, besides 
the conjugation reaction of  bile acids which might be 
mainly affected.
Conclusion
The present study determined the serum level of  bile 
acids in healthy volunteers and patients with colon can-
cers. Compared with the healthy volunteers, the free bile 
acids were detected to increase, and the conjugated bile 
acids were observed to decrease in patients with colon 
cancers. These data provide a new mechanism explana-
tion and the potential biomarkers for colon cancers.
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